BioCatalystWatch
SNSEWorkspace / SNSE / OverviewCompany library
Sensei Biotherapeutics, Inc. logo

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc. (SNSE)

Website

Price
Market cap
Next catalystExpected 2026Sapanisertib + paclitaxel — DICE · Regulatory meetingCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

sapanisertibSapanisertib + paclitaxel — DICE

mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

PIKTOR

PI3Kα × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

PIKTOR

PI3Kα × mTORC1 × mTORC2

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

sapanisertibSapanisertib + paclitaxel — DICE

mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

PIKTOR

PI3Kα × mTORC1 × mTORC2

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

PIKTOR

PI3Kα × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

IEM

PreINDP1P2P3FilingApproved
SNS-102

VSIG4

PreINDP1P2P3FilingApproved
SNS-103

CD39 (ENTPDase1)

PreINDP1P2P3FilingApproved
SNS-201

CD28 × VISTA

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SNSE PR & News

PR & News

SNSE SEC archive